Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Breast Neoplasms 19Carcinoma, Non-Small-Cell Lung 9Rhabdomyosarcoma 6Triple Negative Breast Neoplasms 5Hodgkin Disease 4Recurrence 3Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Neoplasm Metastasis 2Lung Neoplasms 2Adenocarcinoma 2Solitary Fibrous Tumor, Pleural 1NSCLC 1Metastatic HER2-positive Breast Cancer 1Mesothelioma, Malignant 1Lung Diseases, Interstitial 1Locally Advanced Non-Small Cell Lung Cancer 1HR+HER2- Breast Cancer 1HER2-negative Metastatic Breast Cancer 1Fludzoparib" and Anti-angiogenic 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Advanced Breast Cancer 1

Interventions

Cisplatin 2pembrolizumab 1cediranib 1Vinorelbine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Platinum 1Pharmacogenomic Testing 1Pemetrexed 1Neoadjuvant Therapy 1Methotrexate 1Chemotherapy, Adjuvant 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solitary Fibrous Tumor, Pleural × Vinorelbine × 1 year × Clear all
NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

The Cleveland Clinic

Phase 2 Completed
9 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡